Table 3.
Interaction between ACEINH and longitudinal cognitive function change in the Health ABC participants
| p-value for ACEINH × Gene interaction on cognitive decline | ||
|---|---|---|
| Caucasians | African Americans | |
| ACE-ID | ||
| CLOX1 | 0.39 | 0.97 |
| DSST | 0.46 | 0.14 |
| 3MSE | 0.46 | 0.14 |
| AGT6 | ||
| CLOX1 | 0.01 | 0.45 |
| DSST | 0.22 | 0.06 |
| 3MSE | 0.22 | 0.06 |
| AGTM235T | ||
| CLOX1 | 0.01 | 0.64 |
| DSST | 0.15 | 0.12 |
| 3MSE | 0.15 | 0.12 |
CLOX1: Executive clock draw test; DSST: Digit Symbol Substitution Test; 3MSE: Modified Mini Mental Status Examination; p-values are obtained from the Multivariate Mixed Models testing the hypothesis that the gene × ACEINH is significant on the longitudinal change in the cognitive test over the follow-up period. All models adjusted for age, sex, BMI, educational level, systolic blood pressure, stroke, APOE haplotypes, diabetes, baseline CLOX1 scores, and exposure to other high blood pressure medications.